SCHEMBL14973136

SCHEMBL14973136

CCOC(=O)c1cnn(C)c1COc1ccc(F)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 4/20 0.45
RAB9A P51151 4/20 0.45
NPC1 O15118 3/20 0.45
HPGD P15428 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HSD17B10 Q99714 1/20 0.45
GAA P10253 1/20 0.43
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
JMJD6 Q6NYC1 1/20 0.41
P2RX3 P56373 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.39
PDE4B Q07343 1/20 0.39
GABRA5 P31644 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14973295 0.82 NPC1 (0.52) ALDH1A1KDM4ERAB9ANPC1HPGD
SCHEMBL14973085 0.81 ALDH1A1 (0.43) ALDH1A1KDM4ERAB9ANPC1HPGD
SCHEMBL14973111 0.80 PAX8 (0.47) ALDH1A1KDM4ERAB9ANPC1HPGD
SCHEMBL14973299 0.78 JMJD6 (0.45) ALDH1A1KDM4ERAB9ANPC1HPGD
SCHEMBL14973188 0.78 TSHR (0.52) ALDH1A1KDM4ERAB9ANPC1HPGD
SCHEMBL14972991 0.78 GRM5 (0.34) GABRA5CXCR2
SCHEMBL14972989 0.78 GRM5 (0.34) GABRA5CXCR2
SCHEMBL14973126 0.77 MAPT (0.57) ALDH1A1KDM4ERAB9ANPC1HPGD
SCHEMBL14973205 0.77 ALDH1A1 (0.47) ALDH1A1KDM4ERAB9ANPC1HPGD
SCHEMBL14973274 0.76 SMN1; SMN2 (0.52) ALDH1A1KDM4ERAB9ANPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2604602-A1 HETEROARYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-19 EP disclosed
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE GRIN2C, GRIN2B, GRIN3A ALDH1A1 2263/4885KDM4E 4251/4885RAB9A 1090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.